trifluoromethyldeschloroketamine trifluoromethyldeschloroketamine trifluoromethyldeschloroketamine (tfmdck) is a designer drug from the arylcyclohexylamine family, which is presumed to have similar properties to ketamine, a dissociative anesthetic drug with hallucinogenic and sedative effects. it has been sold over the internet since around 2016, though genuine samples appear to be rare. the o-trifluoromethyl analogue of hydroxynorketamine has also been researched as an antidepressant. trifluoromethyldeschloroketamineclinical dataatc codenonelegal statuslegal status ca: schedule i de: npsg (industrial and scientific use only) uk: under psychoactive substances act identifiers iupac name 2-(methylamino)-2-cyclohexan-1-one cas number1782149-73-8 ypubchem cid117067835uniigw3lz66wz6chemical and physical dataformulac14h16f3nomolar mass271.283 g·mol−13d model (jsmol)interactive image smiles cnc1(ccccc1=o)c2=cc=cc=c2c(f)(f)f inchi inchi=1s/c14h16f3no/c1-18-13(9-5-4-8-12(13)19)10-6-2-3-7-11(10)14(15,16)17/h2-3,6-7,18h,4-5,8-9h2,1h3key:lethppjngnsldj-uhfffaoysa-n